Table of Contents USA Xerostomia (Dry Mouth) Therapeutics Market Report 2012-2023 1 Xerostomia (Dry Mouth) Therapeutics Overview 1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics 1.2 Classification of Xerostomia (Dry Mouth) Therapeutics by Product Category 1.2.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Salivary Stimulants 1.2.4 Salivary Substitutes 1.2.5 Dentifrices 1.3 USA Xerostomia (Dry Mouth) Therapeutics Market by Application/End Users 1.3.1 USA Xerostomia (Dry Mouth) Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 OTC 1.3.3 Prescription 1.4 USA Xerostomia (Dry Mouth) Therapeutics Market by Region 1.4.1 USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Xerostomia (Dry Mouth) Therapeutics (2012-2023) 1.5.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics 2.2 Raw Material Analysis of Xerostomia (Dry Mouth) Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Xerostomia (Dry Mouth) Therapeutics 2.4 Other Costs Analysis of Xerostomia (Dry Mouth) Therapeutics 2.5 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics 2.6 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics 2.7 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Xerostomia (Dry Mouth) Therapeutics Players/Suppliers Profiles and Sales Data 3.1 GlaxoSmithKline plc 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 GlaxoSmithKline plc Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.2 Church & Dwight Co., Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Church & Dwight Co., Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.3 Colgate-Palmolive Company 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Colgate-Palmolive Company Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.4 Hikma Pharmaceuticals PLC 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Hikma Pharmaceuticals PLC Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.5 Pendopharm 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pendopharm Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.6 Sun Pharmaceuticals Industries Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sun Pharmaceuticals Industries Ltd. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.7 Lupin Pharmaceuticals, Inc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Lupin Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.8 Pfizer, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Pfizer, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.9 Parnell Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Parnell Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.10 Acacia Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Acacia Pharma Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.11 OraCoat 4 USA Xerostomia (Dry Mouth) Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Xerostomia (Dry Mouth) Therapeutics Market Competition by Players/Manufacturers 4.1.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Type 4.2.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Application 4.3.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application 5 Northeast Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 5.1 Northeast Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 5.1.1 Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 5.3 Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 6 Midwest Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 6.1 Midwest Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 6.1.1 Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 6.3 Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 7 South Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 7.1 South Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 7.1.1 South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 South Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 7.3 South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 8 West Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 8.1 West Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 8.1.1 West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 West Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 8.3 West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) 12.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) 12.2 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2018-2023) 12.3.2 USA Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2018-2023) 12.3.3 USA Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2018-2023) 12.4 USA Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Xerostomia (Dry Mouth) Therapeutics Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Salivary Stimulants Picture Figure Salivary Substitutes Picture Figure Dentifrices Picture Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Applications in 2017 Figure OTC Examples Figure Prescription Examples Figure Examples Table USA Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure South Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure West Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics Table Industry News List of Xerostomia (Dry Mouth) Therapeutics Figure Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2017 Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Basic Information List Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Basic Information List Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Basic Information List Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Basic Information List Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Basic Information List Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Basic Information List Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Basic Information List Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Basic Information List Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Company Acacia Pharma Basic Information List Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales USA Market Share (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue USA Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Xerostomia (Dry Mouth) Therapeutics Sales Share by Players/Manufacturers Table USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Figure 2017 USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate by Type (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Regions in 2017 Table USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2017 Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table USA Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Application (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure South Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure West Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure Northeast Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Type (2018-2023) Table USA Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table USA Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table USA Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure USA Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc Church & Dwight Co., Inc. Colgate-Palmolive Company Hikma Pharmaceuticals PLC Pendopharm Sun Pharmaceuticals Industries Ltd. Lupin Pharmaceuticals, Inc. Pfizer, Inc. Parnell Pharmaceuticals, Inc. Acacia Pharma OraCoat